124 related articles for article (PubMed ID: 1324317)
1. Benzothiazole hydroxy ureas as inhibitors of 5-lipoxygenase: use of the hydroxyurea moiety as a replacement for hydroxamic acid.
Greco MN; Hageman WE; Powell ET; Tighe JJ; Persico FJ
J Med Chem; 1992 Aug; 35(17):3180-3. PubMed ID: 1324317
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives as 5-lipoxygenase inhibitors.
Phillips OA; Bosso MA; Ezeamuzie CI
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1471-1482. PubMed ID: 32635785
[TBL] [Abstract][Full Text] [Related]
3. N-hydroxyurea and hydroxamic acid inhibitors of cyclooxygenase and 5-lipoxygenase.
Connolly PJ; Wetter SK; Beers KN; Hamel SC; Chen RH; Wachter MP; Ansell J; Singer MM; Steber M; Ritchie DM; Argentieri DC
Bioorg Med Chem Lett; 1999 Apr; 9(7):979-84. PubMed ID: 10230624
[TBL] [Abstract][Full Text] [Related]
4. Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors.
Satoh Y; Stanton JL; Hutchison AJ; Libby AH; Kowalski TJ; Lee WH; White DH; Kimble EF
J Med Chem; 1993 Nov; 36(23):3580-94. PubMed ID: 8246226
[TBL] [Abstract][Full Text] [Related]
5. Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenase.
Malamas MS; Carlson RP; Grimes D; Howell R; Glaser K; Gunawan I; Nelson JA; Kanzelberger M; Shah U; Hartman DA
J Med Chem; 1996 Jan; 39(1):237-45. PubMed ID: 8568813
[TBL] [Abstract][Full Text] [Related]
6. New Zileuton-Hydroxycinnamic Acid Hybrids: Synthesis and Structure-Activity Relationship towards 5-Lipoxygenase Inhibition.
Chiasson AI; Robichaud S; Ndongou Moutombi FJ; Hébert MPA; Mbarik M; Surette ME; Touaibia M
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066378
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.
Oketani K; Nagakura N; Harada K; Inoue T
Eur J Pharmacol; 2001 Jun; 422(1-3):209-16. PubMed ID: 11430933
[TBL] [Abstract][Full Text] [Related]
8. Development of 2,3-dihydro-6-(3-phenoxypropyl)-2-(2-phenylethyl)-5-benzofuranol (L-670,630) as a potent and orally active inhibitor of 5-lipoxygenase.
Lau CK; Bélanger PC; Dufresne C; Scheigetz J; Therien M; Fitzsimmons B; Young RN; Ford-Hutchinson AW; Riendeau D; Denis D
J Med Chem; 1992 Apr; 35(7):1299-318. PubMed ID: 1313879
[TBL] [Abstract][Full Text] [Related]
9. Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma.
Payne AN; Jackson WP; Salmon JA; Nicholls A; Yeadon M; Garland LG
Agents Actions Suppl; 1991; 34():189-99. PubMed ID: 1793063
[TBL] [Abstract][Full Text] [Related]
10. Discovery of potential anti-inflammatory drugs: diaryl-1,2,4-triazoles bearing N-hydroxyurea moiety as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase.
Jiang B; Huang X; Yao H; Jiang J; Wu X; Jiang S; Wang Q; Lu T; Xu J
Org Biomol Chem; 2014 Apr; 12(13):2114-27. PubMed ID: 24562695
[TBL] [Abstract][Full Text] [Related]
11. Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity.
Hamer RR; Tegeler JJ; Kurtz ES; Allen RC; Bailey SC; Elliott ME; Hellyer L; Helsley GC; Przekop P; Freed BS; White J; Martin LL
J Med Chem; 1996 Jan; 39(1):246-52. PubMed ID: 8568814
[TBL] [Abstract][Full Text] [Related]
12. Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors.
Crawley GC; Dowell RI; Edwards PN; Foster SJ; McMillan RM; Walker ER; Waterson D; Bird TG; Bruneau P; Giroaeau JM
J Med Chem; 1992 Jul; 35(14):2600-9. PubMed ID: 1321908
[TBL] [Abstract][Full Text] [Related]
13. Novel bishydroxamic acids as 5-lipoxygenase inhibitors.
Ohemeng KA; Nguyen VN; Schwender CF; Singer M; Steber M; Ansell J; Hageman W
Bioorg Med Chem; 1994 Mar; 2(3):187-93. PubMed ID: 7922131
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 5-lipoxygenase: development of hydroxamic acids and hydroxyureas as potential therapeutic agents.
Salmon JA; Jackson WP; Garland LG
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():109-12. PubMed ID: 1847758
[No Abstract] [Full Text] [Related]
15. Structure-activity relationships of (E)-3-(1,4-benzoquinonyl)-2-[(3-pyridyl)-alkyl]-2-propenoic acid derivatives that inhibit both 5-lipoxygenase and thromboxane A2 synthetase.
Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Harada K; Miyamoto K; Yamatsu I
J Med Chem; 1996 Aug; 39(16):3148-57. PubMed ID: 8759636
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, chemical, and biological properties of vinylogous hydroxamic acids: dual inhibitors of 5-lipoxygenase and IL-1 biosynthesis.
Wright SW; Harris RR; Kerr JS; Green AM; Pinto DJ; Bruin EM; Collins RJ; Dorow RL; Mantegna LR; Sherk SR
J Med Chem; 1992 Oct; 35(22):4061-8. PubMed ID: 1433212
[TBL] [Abstract][Full Text] [Related]
17. Nitroxide metabolites from alkylhydroxylamines and N-hydroxyurea derivatives resulting from reductive inhibition of soybean lipoxygenase.
Chamulitrat W; Mason RP; Riendeau D
J Biol Chem; 1992 May; 267(14):9574-9. PubMed ID: 1315759
[TBL] [Abstract][Full Text] [Related]
18. Novel dual inhibitors of 5-lipoxygenase and thromboxane A2 synthetase: synthesis and structure-activity relationships of 3-pyridylmethyl-substituted 2-amino-6-hydroxybenzothiazole derivatives.
Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Murakami M; Oketani K; Inoue T
J Med Chem; 1994 Sep; 37(19):3062-70. PubMed ID: 7932529
[TBL] [Abstract][Full Text] [Related]
19. Criteria for the identification of non-redox inhibitors of 5-lipoxygenase.
Falgueyret JP; Hutchinson JH; Riendeau D
Biochem Pharmacol; 1993 Feb; 45(4):978-81. PubMed ID: 8452572
[TBL] [Abstract][Full Text] [Related]
20. N-Aminoindoline derivatives as inhibitors of 5-lipoxygenase.
Audouin C; Mestdagh N; Lassoie MA; Houssin R; Hénichart JP
Bioorg Med Chem Lett; 2001 Mar; 11(6):845-8. PubMed ID: 11277534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
